AstraZeneca (Sweden)

9.6k papers and 388.0k indexed citations i.

About

In recent decades, authors affiliated with AstraZeneca (Sweden) have published 9.6k papers, which have received a total of 388.0k indexed citations. Scholars at this organization have produced 2.8k papers in Molecular Biology, 1.3k papers in Physiology and 1.3k papers in Surgery on the topics of Asthma and respiratory diseases (635 papers), Analytical Chemistry and Chromatography (536 papers) and Diabetes Treatment and Management (526 papers). Their work is cited by papers focused on Molecular Biology (114.1k citations), Surgery (53.9k citations) and Physiology (51.7k citations). Authors at AstraZeneca (Sweden) collaborate with scholars in Sweden, United Kingdom and United States and have published in prestigious journals including Nature, Science and Cell. Some of AstraZeneca (Sweden)'s most productive authors include Svante B. Ross, Magnus Åstrand, Rafael A. Irizarry, Benjamin M. Bolstad, Terence P. Speed, Christer Köhler, Jonas Boström, Tommy B. Andersson, John J.V. McMurray and Tudor I. Oprea.

In The Last Decade

Fields of papers published by authors at AstraZeneca (Sweden)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AstraZeneca (Sweden) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AstraZeneca (Sweden) at the time of their publication.

Countries citing scholars working at AstraZeneca (Sweden)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AstraZeneca (Sweden). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (Sweden) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (Sweden) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025